John D. Minna

Active 1971–2025

Also published as
JOHN D. MINNA
440
Papers
101,471
Citations
176
h-index
431
i10-index

Citations

Citations per year for John D. Minna1944: 1 citations1951: 1 citations1963: 1 citations1970: 1 citations1971: 5 citations1972: 8 citations1973: 13 citations1974: 17 citations1975: 9 citations1976: 19 citations1977: 9 citations1978: 17 citations1979: 22 citations1980: 15 citations1981: 44 citations1982: 87 citations1983: 140 citations1984: 176 citations1985: 189 citations1986: 199 citations1987: 219 citations1988: 227 citations1989: 237 citations1990: 270 citations1991: 314 citations1992: 275 citations1993: 293 citations1994: 241 citations1995: 211 citations1996: 240 citations1997: 231 citations1998: 233 citations1999: 358 citations2000: 318 citations2001: 442 citations2002: 595 citations2003: 563 citations2004: 647 citations2005: 773 citations2006: 622 citations2007: 764 citations2008: 890 citations2009: 764 citations2010: 977 citations2011: 942 citations2012: 845 citations2013: 915 citations2014: 780 citations2015: 817 citations2016: 852 citations2017: 741 citations2018: 708 citations2019: 2,301 citations2020: 2,413 citations2021: 2,498 citations2022: 2,084 citations2023: 1,546 citations2024: 2,380 citations2025: 1,196 citations2026: 36 citations1945–1950: no citations, so these years are not shown1952–1962: no citations, so these years are not shown1964–1969: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 11,405 citing papers, 32.8% of this breakdownChina: 4,422 citing papers, 12.7% of this breakdownUnited Kingdom: 1,930 citing papers, 5.6% of this breakdownJapan: 1,709 citing papers, 4.9% of this breakdownGermany: 1,534 citing papers, 4.4% of this breakdownItaly: 1,212 citing papers, 3.5% of this breakdownFrance: 1,119 citing papers, 3.2% of this breakdownCanada: 1,021 citing papers, 2.9% of this breakdownSpain: 800 citing papers, 2.3% of this breakdownSouth Korea: 744 citing papers, 2.2% of this breakdownAustralia: 728 citing papers, 2.1% of this breakdownNetherlands: 628 citing papers, 1.8% of this breakdown
0%32.8%Other 21.6%

Fields

  • Biochemistry, Genetics and Molecular Biology43.3%
  • Medicine42.9%
  • Immunology and Microbiology6.6%
  • Neuroscience1.9%
  • Computer Science1.4%
  • Engineering0.7%
  • Other3.2%

Topics

  • Lung Cancer Treatments and Mutations4.5%
  • Lung Cancer Research Studies3.2%
  • Epigenetics and DNA Methylation3.1%
  • Cancer Genomics and Diagnostics2.9%
  • RNA modifications and cancer2.8%
  • Cancer-related Molecular Pathways2.3%
  • Other81.2%

Coauthors

All papers

Open in search
  1. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2021 cited by 932

  2. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data

    Authors: , , , , , , , , , , , , , , , , , - Nature reviews. Cancer 2019 cited by 1,275

  3. Co-occurring Genomic Alterations Define Major Subsets of KRAS -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Waun Ki Hong, John D. Minna, James P. Allison, P. Andrew Futreal, Jing Wang, Ignacio I. Wistuba, John V. Heymach - Cancer Discovery 2015 cited by 916

  4. Mechanical regulation of glycolysis via cytoskeleton architecture

    Authors: , , , , , , , , , , , - Nature 2020 cited by 611

  5. Small-cell lung cancer: what we know, what we need to know and the path forward

    Authors: , , - Nature reviews. Cancer 2017 cited by 920

  6. MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2023 cited by 178

  7. ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs

    Authors: , , , , , , , , , , - Cell Reports 2016 cited by 530

  8. NRF2 regulates serine biosynthesis in non–small cell lung cancer

    Authors: , , , , , , , , , , , , , - Nature Genetics 2015 cited by 778

  9. Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2014 cited by 1,744

  10. Artificial Intelligence in Lung Cancer Pathology Image Analysis

    Authors: , , , , , , , , , - Cancers 2019 cited by 297

  11. An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ignacio I. Wistuba, Kevin R. Coombes, John D. Minna, John V. Heymach - Clinical Cancer Research 2012 cited by 1,121

  12. Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 170

  13. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marileila Varella‐Garcia, Adi F. Gazdar, Frédéric J. de Sauvage, Richard Bourgon, John D. Minna, Malcolm V. Brock, Somasekar Seshagiri - Nature Genetics 2012 cited by 1,098

  14. Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2024 cited by 157

  15. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS -Mutant Lung Adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , - Cancer Research 2019 cited by 274

  16. Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis

    Authors: , , , , , , , , , , , , , , , , , , - Cell Reports 2016 cited by 309

  17. Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes

    Authors: , , , , , , , , , , - Translational Lung Cancer Research 2018 cited by 281

  18. CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2023 cited by 104

  19. Systematic investigation of mitochondrial transfer between cancer cells and T cells at single-cell resolution

    Authors: , , , , , , , , , , , , , , , - Cancer Cell 2023 cited by 116

  20. Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2012 cited by 571

  21. CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2017 cited by 314

  22. ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers

    Authors: , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 283

  23. Computational Staining of Pathology Images to Study the Tumor Microenvironment in Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , - Cancer Research 2020 cited by 147

  24. SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures

    Authors: , , , , , , , , , , , , , , , , , , - Cell Reports 2020 cited by 168